XML 47 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Summary of Significant Accounting Policies  
Schedule of cash and cash equivalents

Cash and cash equivalents consist of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

December 31, 

 

    

2019

    

2018

Cash

 

$

2,530

 

$

4,390

Money market fund

 

 

5,432

 

 

5,956

Corporate debt securities

 

 

1,937

 

 

1,948

Reverse repurchase agreements

 

 

 —

 

 

3,000

Total

 

$

9,899

 

$

15,294

 

Schedule of reconciliation of cash, cash equivalents and restricted cash

 

 

 

 

 

 

 

 

 

 

December 31, 

 

    

2019

    

2018

Cash and cash equivalents

 

$

9,899

 

$

15,294

Restricted cash (1)

 

 

477

 

 

113

Total

 

$

10,376

 

$

15,407


(1)  Included in prepaid expenses and other current assets and other assets as of December 31, 2019 and other assets as of December 31, 2018 in the consolidated balance sheets

 

Schedule of stock-based compensation expense

During the years ended December 31, 2019 and 2018, the Company recorded stock-based compensation expense for employee and non-employee stock options and restricted stock, which was allocated as follows in the statements of operations (in thousands): 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2019

    

2018

Research and development

 

$

616

 

$

673

General and administrative

 

 

896

 

 

1,098

Total

 

$

1,512

 

$

1,771

 

Schedule of anti-dilutive common stock equivalents excluded from calculation of diluted net loss per share

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2019

    

2018

Stock options

 

785,832

 

433,389

Common stock warrants

 

6,193,749

 

4,202,449

 

 

6,979,581

 

4,635,838